Vasorelaxation of rat thoracic aorta caused by 14-deoxyandrographolide

Clinical and Experimental Pharmacology and Physiology

Volumn 25, Issue 6, 1998, Pages 424-429

  Zhang, C Y ^a   Tan, B K H ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

14 Deoxyandrographolide; Aorta; Ca2+ influx; Nitric oxide; Vasorelaxation

Indexed keywords

14 DEOXYANDROGRAPHOLIDE; ANDROGRAPHIS PANICULATA EXTRACT; CAFFEINE; CALCIUM CHANNEL; CALCIUM ION; GLIBENCLAMIDE; GUANYLATE CYCLASE; INDOMETACIN; METHYLENE BLUE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NORADRENALIN; PHENYLEPHRINE; POTASSIUM CHLORIDE; UNCLASSIFIED DRUG; VERAPAMIL;

ANIMAL TISSUE; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTICLE; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; MALE; NONHUMAN; RAT; THORACIC AORTA; VASODILATATION;

EID: 0031862598     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1998.tb02226.x     Document Type: Article

References (27)

1. Ahmad M, Asmawi MZ. Some pharmacological effects of aqueous extract of Andrographis paniculata Nees. In: Gan EK (ed.). The International Conference on the Use of Traditional Medicine and Other Natural Products in Health-Care (Abstracts). University of Science Malaysia, Kuala Lumpur, Malaysia. 1993; 122.
2. Zhang CY, Tan BKH. Hypertensive activity of aqueous extract of Andrographis paniculata in rats. Clin. Exp. Pharmacol. Physiol. 1996; 23: 675-8
3. Balmain A, Connolly JD. Minor diterpenoid constituents of Andrographis paniculata Nees. J. Chem. Soc. 1973; i: 1247-51.
4. Matsuda T, Kuroyanagi M, Sugiyama S, Umehara K, Ueno A, Nishi K. Cell differentiation-inducing diterpenes from Andrographis paniculata Nees. Chem. Pharm. Bull. 1994; 42: 1216-25.
5. Deng WL, Nie RJ, Liu JY. Comparison of pharmacological effect of four andrographolides. Chin. Pharm. Bull. 1982; 17: 195-8.
6. 2+ level in rat aorta. Br. J. Pharmacol. 1991; 102: 174-8.
7. 2+ in rabbit aortic smooth muscle by norepinephrine and potassium after exposure to lanthanum and low temperature. J. Pharmacol. Exp. Ther. 1979; 221: 86-92.
8. Karaki H, Weiss GB. Calcium channels in smooth muscle. Gastroenterology 1984; 87: 960-70.
9. Marriott JF. A comparison of the effects of the calcium entry blockers, verapamil, diltiazem and flunarizine against contractions of the rat isolated aorta and portal vein. Br. J. Pharmacol. 1988; 95: 145-54.
10. Bolton TB. Mechanism of action of transmitters and other substances on smooth muscle. Physiol. Rev. 1979; 59: 607-718.
11. 2+ Entry Blockers, Adenosine and Neurohumors. Urban and Schwarzenberg, Baltimore. 1983; 63-72.
12. 2+ localization and sensitivity in vascular smooth muscle. Trends Pharmacol. Sci. 1989; 10: 320-5.
13. Flaim SF. Comparative pharmacology of calcium blockers based on studies of vascular smooth muscle. In: Flaim SF, Zelis R (eds). Calcium Blockers. Urban and Schwarzenberg, New York. 1982; 155-78.
14. Karaki H, Weiss GB. Minireview: Calcium release in smooth muscle. Life Sci. 1988; 42: 111-22.
15. Noguera MA, D'Ocon MP. Different and common intracellular calcium-stores mobilized by noradrenaline and caffeine in vascular smooth muscle. Naunyn Schmiedebergs Arch. Pharmacol. 1992; 435: 333-41.
16. 2+ store in vascular smooth muscle. Nature 1984; 281: 682-3.
17. Hashimoto T, Hirata M, Itoh T, Kanmura Y, Kuriyama H. Inositol 1,4,5-trisphosphate activates pharmaco-mechanical coupling in smooth muscle of the rabbit mesenteric artery. J. Physiol. 1986; 370: 605-18.
18. 1-adrenoceptor stimulation in the rat aorta. J. Pharmacol. Exp. Ther. 1987; 240: 123-7.
19. 2-adrenoceptors in several blood vessels isolated from the rabbit. Br. J. Pharmacol. 1990; 99: 253-6.
20. 2+ storage site differs from the caffeine-sensitive site in vascular smooth muscle of the rat aorta. FEBS Lett. 1987; 214: 130-4.
21. Jaffe EA. Physiological functions of normal endothelial cells. Ann. N.Y. Acad. Sci. 1985; 454: 279-91.
22. Vanhoutte PM, Rubanyi GM, Miller VM, Houston DS. Modulation of vascular smooth muscle contraction by endothelium. Annu. Rev. Physiol. 1986; 48: 307-30.
23. Persson PB. Modulation of cardiovascular control mechanisms and their interaction. Physiol. Rev. 1996; 76: 193-244.
24. Luscher TF. Local relaxant and constricting factors in the vessel wall. In: Swales JD (ed.). Textbook of Hypertension. Blackwell Science, London. 1994; 145-59.
25. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-6.
26. Myers PR Jr, Minor RL Jr, Guerra R, Bates JN, Harrison DG. Vasorelaxant properties of endothelium-derived relaxing factor more closely resemble 5-nitrosocysteine than nitric oxide. Nature 1990; 345: 161-3.
27. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 1991; 43: 109-12.